Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Characterization of a eukaryotic-like protein kinase, DspB, with an atypical catalytic loop motif from Myxococcus xanthus.
Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.
Interaction Study of Phospholipid Membranes with an N-Glucosylated β-Turn Peptide Structure Detecting Autoantibodies Biomarkers of Multiple Sclerosis.
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.
Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report.
Radiolabeled anti-aquaporin-4 protein antibody imaging: a valuable method for determining neuromyelitis optica.
Let's rehabilitate cognitive rehabilitation in multiple sclerosis.
Chronic inflammatory demyelinating polyneuropathy with papillodema and response to immunoglobulins.
Activation of oligodendroglial Stat3 is required for efficient remyelination.
The role of Candida albicans in the severity of multiple sclerosis.
Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease.
T cell chemokine receptor patterns as pathogenic signatures in autoimmunity.
Does the changing sex ratio of multiple sclerosis give opportunities for intervention?
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
Body Esteem Among Women with Multiple Sclerosis and its Relationship with Demographic, Clinical and Socio-Psychological Factors.
Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2.
MAIT cells in autoimmunity, immune mediated diseases and airways disease.
Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales.
Neurological and functional recovery in acute transverse myelitis patients with inpatient rehabilitation and magnetic resonance imaging correlates.
Diagnostic work-up and therapeutic options in management of pediatric status epilepticus.
Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran.
Examination of the Chicago Multiscale Depression Inventory and Initial Validation of a Positive Scale.
Editorial: Fatigue in Multiple Sclerosis.
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV.
Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.
Pages
« first
‹ previous
…
695
696
697
698
699
700
701
702
703
…
next ›
last »